Diabetes and Vascular Disease

Lower extremity arterial disease (LEAD) is clinically identified by intermittent claudication and/or absence of peripheral pulses in the lower legs and feet. These clinical manifestations reflect decreased arterial perfusion of the extremity. With the use of Doppler technology and blood pressure measurements of the extremity, LEAD can be identified noninvasively before clinical manifestation. X-ray of the extremities can detect arterial calcification that is indicative of arterial disease with or without an occlusive component. The incidence and prevalence of LEAD increase with age in both diabetic and nondiabetic subjects and, in those with diabetes, increase with duration of diabetes. Many elderly diabetic persons have LEAD at the time of diabetes diagnosis. Diabetes is an important risk factor for LEAD. Hypertension, smoking, and hyperlipidemia, which are frequently present in patients with diabetes, contribute additional risk for vascular disease.

 

  • Doppler technology
  • Lower extremity arterial disease
  • Hyperlipidemia
  • Hypertension

Related Conference of Diabetes and Vascular Disease

May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Diabetes and Vascular Disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in